6.410USDMkt Cap: 640.89M $P/E: —1d ago
Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company of…
Industry Peers
Medical Care FacilitiesIndicators:|
Key Statistics
Company
Market Cap640.89M $
Enterprise Value573.55M $
Revenue (TTM)545.76M $
Gross Profit76.44M $
Net Income (TTM)-60.61M $
Revenue/Share5.537 USD
Last Price6.410 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees641
CountryUS
SectorHealthcare
IndustryMedical Care Facilities
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-22.14
EV/Revenue1.05
P/S1.17
P/B-39.33
EPS (TTM)-0.35
EPS (Forward)—
52W Range
6.02038% of range7.050
52W High7.050 USD
52W Low6.020 USD
Profitability
Gross Margin15.20%
Oper. Margin-4.42%
EBITDA Margin-4.75%
Profit Margin-12.06%
ROE385.53%
ROA-36.81%
Growth
Revenue Growth41.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-24.59M $
CapEx (TTM)3.20M $
FCF Margin-2.81%
FCF Yield-2.39%
Net Debt74.63M $
Net Debt/EBITDA-2.88
Balance Sheet
Debt/Equity-6.60
Current Ratio1.47
Quick Ratio1.13
Book Value/Sh-0.1630 USD
Cash/Share0.3030 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)8.400 USD
Upside (mean)+31.0%
Target Range7.000 USD – 10.00 USD
$7.000+31.0% to mean$10.00
# Analysts5
Ownership
Shares Out.99.98M
Float86.67M
Insiders18.42%
Institutions46.11%
Short Interest
Short Ratio3.3d
Short % Float8.30%
Short % Out.7.27%
Shares Short7.27M
Short (prev mo.)6.69M
Technical
SMA 505.029 (+27.5%)
SMA 2005.029 (+27.5%)
Beta0.42
S&P 52W Chg18.95%
Avg Vol (30d)6.57M
Avg Vol (10d)1.34M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—